Papers
3
Total Citations
59
H-Index
2
About
R. Faccini is a pioneering researcher at the intersection of nuclear medicine and surgical robotics, specializing in radioguided surgery for prostate cancer. Their major contributions center on the development and validation of the DROP-IN β-probe, a flexible device designed for robot-assisted procedures that leverages beta-emitting PET isotopes—such as ⁶⁸Ga-PSMA—for real-time tumor detection. Faccini’s landmark 2020 study, cited 43 times, provided the first ex vivo evaluation of this technology using prostate cancer specimens, demonstrating its potential to overcome limitations of traditional gamma probes. This work laid the foundation for their 2024 first-in-human validation (14 citations), which defined optimal signal-to-background discrimination algorithms for clinical use. By integrating preoperative PET/CT roadmaps with intraoperative beta detection, Faccini has advanced the precision of radioguided surgery, enabling more complete tumor resections while sparing healthy tissue. Their research bridges engineering and oncology, offering a transformative tool for minimally invasive cancer care. With growing citation impact, Faccini’s work is shaping the next generation of targeted, robot-assisted surgical interventions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3